mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathySteven Hyun Seung Lee, Heuiran Lee|PLoS ONE|2022Cited by 13
Intravitreally Administered Soluble VEGF Receptor-1 Variant Tested as a Potential Gene Therapeutic for Diabetic RetinopathySteven Hyun Seung Lee, Heuiran Lee|Advances in Cell and Gene Therapy|2022Cited by 3
An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1Seo Yun Moon, Steven Hyun Seung Lee|PLoS ONE|2024Cited by 1